Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Shares Outstanding 2017–2025
Aclaris Therapeutics, Inc. annual/quarterly shares outstanding history and growth rate from 2017 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Aclaris Therapeutics, Inc. shares outstanding for the quarter ending March 31, 2026 was 0.13 B shs, a 5.25% increase year-over-year.
- Aclaris Therapeutics, Inc. annual shares outstanding for 2025 was 0.12 B shs, a 58.56% increase from 2024.
- Aclaris Therapeutics, Inc. annual shares outstanding for 2024 was 0.08 B shs, a 10.73% increase from 2023.
- Aclaris Therapeutics, Inc. annual shares outstanding for 2023 was 0.07 B shs, a 7.05% increase from 2022.
- Aclaris Therapeutics, Inc. annual shares outstanding for 2022 was 0.07 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Aclaris Therapeutics, Inc. Shares Outstanding — FAQ
Aclaris Therapeutics, Inc. (ACRS) shares outstanding over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Aclaris Therapeutics, Inc.'s shares outstanding?
Aclaris Therapeutics, Inc. (ACRS) reported shares outstanding of 0.12B shares for fiscal 2025.
Where can I see ACRS's shares outstanding history?
The chart and table above show Aclaris Therapeutics, Inc.'s shares outstanding by year and by quarter, including the growth rate.